Aclaris Therapeutics (ACRS) Stock Chart & Stock Price History $1.61 +0.02 (+1.26%) Closing price 04:00 PM EasternExtended Trading$1.56 -0.05 (-3.11%) As of 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aclaris Therapeutics Stock Price Performance The Aclaris Therapeutics (ACRS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 22.90%, with a year-to-date return of -35.08%. In the past month, the stock has increased 13.38%, reflecting recent market activity. As of the latest close, Aclaris Therapeutics traded at $1.59 with a market cap of $172.17 million and volume of 549,795 shares. Five years ago, the stock traded at $2.21, representing a 27.15% decrease over that period. At the time, it had a market cap of $90.02 million and a volume of 1.09 million shares. Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+2.55%1 Month Performance+13.38%3 Month Performance+41.23%Year-To-Date Performance-35.08%1 Year Performance+22.90%5 Year Performance-27.15% ACRS Stock Chart for Friday, July, 18, 2025 ACRS Chart by TradingView Aclaris Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/18/2025$1.59$1.61+1.26%$1.63$1.58650,344 shs$174.33 million07/17/2025$1.58$1.59+0.63%$1.63$1.56549,795 shs$172.17 million07/16/2025$1.52$1.58+3.95%$1.58$1.51507,657 shs$171.08 million07/15/2025$1.58$1.52-3.80%$1.60$1.52556,503 shs$164.59 million07/14/2025$1.57$1.58+0.64%$1.68$1.56902,887 shs$171.08 million07/11/2025$1.59$1.57-1.26%$1.61$1.54585,136 shs$170 million07/10/2025$1.54$1.59+3.25%$1.63$1.541.27 million shs$172.17 million07/09/2025$1.45$1.54+6.21%$1.57$1.44622,965 shs$166.75 million07/08/2025$1.46$1.45-0.68%$1.50$1.45576,608 shs$157.01 million07/07/2025$1.45$1.46+1.04%$1.50$1.44567,998 shs$158.09 million Get the Latest News and Ratings for ACRS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/04/2025$1.45$1.45$1.49$1.44402,410 shs$156.47 million07/03/2025$1.45$1.45-0.34%$1.49$1.44402,410 shs$156.47 million07/02/2025$1.41$1.45+2.84%$1.52$1.39733,074 shs$157.01 million07/01/2025$1.42$1.41-0.70%$1.47$1.38715,066 shs$152.68 million06/30/2025$1.47$1.42-3.40%$1.47$1.39965,844 shs$153.76 million06/27/2025$1.56$1.47-5.77%$1.63$1.4211.53 million shs$159.17 million06/26/2025$1.63$1.56-4.29%$1.66$1.55991,432 shs$168.92 million06/25/2025$1.52$1.63+7.24%$1.63$1.54947,692 shs$176.50 million06/24/2025$1.39$1.52+9.35%$1.52$1.39681,359 shs$164.59 million06/23/2025$1.45$1.39-4.14%$1.46$1.341.47 million shs$150.51 million06/20/2025$1.42$1.45+2.11%$1.45$1.40887,057 shs$157.01 million06/19/2025$1.42$1.42$1.46$1.37738,101 shs$153.76 million06/18/2025$1.40$1.42+1.43%$1.46$1.37738,101 shs$153.76 million06/17/2025$1.44$1.40-2.78%$1.49$1.40522,832 shs$151.59 million Related Companies Maravai LifeSciences Stock Chart Iovance Biotherapeutics Stock Chart Urogen Pharma Stock Chart Tilray Brands Stock Chart Tango Therapeutics Stock Chart Stoke Therapeutics Stock Chart Prime Medicine Stock Chart Dianthus Therapeutics Stock Chart Phathom Pharmaceuticals Stock Chart Upstream Bio Stock Chart Receive ACRS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aclaris Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACRS) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclaris Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclaris Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
